Drugs that contain Diclofenac Potassium
1. Drug name - CAMBIA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8097651 | ASSERTIO | Diclofenac formulations and methods of use |
Jun, 2026
(3 years from now) | |
| US7759394 | ASSERTIO | Diclofenac formulations and methods of use |
Jun, 2026
(3 years from now) | |
| CN101272768A | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Nov, 2015
(6 years ago) | |
| EP2705837A1 | ASSERTIO | Diclofenac Formulation |
Jun, 2026
(3 years from now) | |
| EP2705837B1 | ASSERTIO | Diclofenac Formulation |
Jun, 2026
(3 years from now) | |
| EP1890680A2 | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Jun, 2026
(3 years from now) | |
| EP2402003B1 | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Jun, 2026
(3 years from now) | |
| EP3103441A1 | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Jun, 2026
(3 years from now) | |
| EP2402003A2 | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Jun, 2026
(3 years from now) | |
| EP3103441B1 | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Jun, 2026
(3 years from now) | |
| EP1890680B1 | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Jun, 2026
(3 years from now) | |
| EP2402003A3 | ASSERTIO | Diclofenac Formulations And Methods Of Use |
Jun, 2026
(3 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8927604 | ASSERTIO | Diclofenac formulations and methods of use |
Jun, 2026
(3 years from now) | |
| US9827197 | ASSERTIO | Diclofenac formulations and methods of use |
Jun, 2026
(3 years from now) | |
Treatment: Acute treatment of migraine attacks with or without aura in adults
Dosage: FOR SOLUTION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 50MG | FOR SOLUTION;ORAL | Prescription |
2. Drug name - ZIPSOR
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9561200 | ASSERTIO | Method of treating post-surgical acute pain |
Feb, 2029
(6 years from now) | |
| US7884095 | ASSERTIO | Method of treating post-surgical acute pain |
Feb, 2029
(6 years from now) | |
| US8110606 | ASSERTIO | Method of treating post-surgical acute pain |
Feb, 2029
(6 years from now) | |
| US7662858 | ASSERTIO | Method of treating post-surgical acute pain |
Feb, 2029
(6 years from now) | |
| US7939518 | ASSERTIO | Method of treating post-surgical acute pain |
Feb, 2029
(6 years from now) | |
| US8623920 | ASSERTIO | Method of treating post-surgical acute pain |
Feb, 2029
(6 years from now) | |
Treatment: Diclofenac potassium for relief of mild to moderate acute pain; Nonsteroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain
Dosage: CAPSULE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 25MG | CAPSULE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.